Structural basis of Nipah virus RNA synthesis.

Structural basis of Nipah virus RNA synthesis.

Publication date: Mar 06, 2025

Nipah virus (NiV) is a non-segmented negative-strand RNA virus (nsNSV) with high pandemic potential, as it frequently causes zoonotic outbreaks and can be transmitted from human to human. Its RNA-dependent RNA polymerase (RdRp) complex, consisting of the L and P proteins, carries out viral genome replication and transcription and is therefore an attractive drug target. Here, we report cryo-EM structures of the NiV polymerase complex in the apo and in an early elongation state with RNA and incoming substrate bound. The structure of the apo enzyme reveals the architecture of the NiV L-P complex, which shows a high degree of similarity to other nsNSV polymerase complexes. The structure of the RNA-bound NiV L-P complex shows how the enzyme interacts with template and product RNA during early RNA synthesis and how nucleoside triphosphates are bound in the active site. Comparisons show that RNA binding leads to rearrangements of key elements in the RdRp core and to ordering of the flexible C-terminal domains of NiV L required for RNA capping. Taken together, these results reveal the first structural snapshots of an actively elongating nsNSV L-P complex and provide insights into the mechanisms of genome replication and transcription by NiV and related viruses.

Open Access PDF

Concepts Keywords
Attractive Catalytic Domain
Genome Cryoelectron Microscopy
Pandemic Humans
Triphosphates Models, Molecular
Zoonotic Nipah Virus
RNA-Dependent RNA Polymerase
RNA-Dependent RNA Polymerase
RNA, Viral
RNA, Viral
Viral Proteins
Viral Proteins
Virus Replication

Semantics

Type Source Name
disease IDO replication
disease IDO site
disease MESH causes
drug DRUGBANK ANX-510
disease IDO protein
disease MESH Nipah virus infection
disease IDO pathogen
drug DRUGBANK Coenzyme M
drug DRUGBANK Heparin
drug DRUGBANK ATP
drug DRUGBANK Guanosine
drug DRUGBANK Cytidine
disease MESH Influenza
drug DRUGBANK Ademetionine
pathway REACTOME Methylation
drug DRUGBANK Gold
disease IDO facility
drug DRUGBANK Phosphate ion
drug DRUGBANK Isopropyl Alcohol
disease IDO reagent
drug DRUGBANK Glycerin
drug DRUGBANK Edetic Acid
drug DRUGBANK Methylergometrine
drug DRUGBANK Imidazole
drug DRUGBANK Maltose
drug DRUGBANK Flunarizine
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Trypsin
drug DRUGBANK Nitrogen
pathway REACTOME Release
pathway REACTOME Acetylation
disease IDO assay
drug DRUGBANK Urea
drug DRUGBANK Activated charcoal
drug DRUGBANK Titanium
disease MESH virus disease
disease IDO cell
pathway REACTOME mRNA Capping
drug DRUGBANK Histidine
disease MESH parainfluenza
disease IDO production
drug DRUGBANK Troleandomycin
pathway REACTOME Reproduction

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *